0001209191-20-008889.txt : 20200212 0001209191-20-008889.hdr.sgml : 20200212 20200212172224 ACCESSION NUMBER: 0001209191-20-008889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200210 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 20605570 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-02-10 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Chief Patient Officer Common Stock 2020-02-10 4 F 0 12215 240.95 D 59268 D Common Stock 2020-02-11 4 S 0 1000 243.53 D 58268 D Common Stock 2020-02-11 4 S 0 3426 245.05 D 54842 D Common Stock 2020-02-11 4 S 0 4320 245.99 D 50522 D Common Stock 2020-02-11 4 S 0 1821 246.88 D 48701 D Common Stock 2020-02-11 4 S 0 2103 247.98 D 46598 D Common Stock 2020-02-11 4 S 0 400 248.73 D 46198 D Common Stock 16190 I Held in Trust Common Stock 882 I 401(k) Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $243.53 (range $242.88 to $243.86). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $245.05 (range $244.50 to $245.47). Open market sales reported on this line occurred at a weighted average price of $245.99 (range $245.50 to $246.45). Open market sales reported on this line occurred at a weighted average price of $246.88 (range $246.53 to $247.39). Open market sales reported on this line occurred at a weighted average price of $247.98 (range $247.55 to $248.50). Open market sales reported on this line occurred at a weighted average price of $248.73 (range $248.60 to $248.82). /s/ Omar White, Attorney-in-Fact 2020-02-12